Kala Pharmaceuticals Adds 6% In Morning Trade

On:

Shares of Kala Pharmaceuticals, Inc. (KALA) are rising more than 6% Friday morning at $16.43.

The company today said Combangio, Inc., a unit of Kala, has been awarded a $15 million grant by the California Institute for Regenerative Medicine (CIRM) to support the company’s ongoing study of KPI-012 for the treatment of persistent corneal epithelial defect (PCED).

KALA has traded in the range of $3.54-$56.72 in the last 1 year.

Source: Read Full Article

Lates News:
  1. There Is A "Good Chance" Ethereum Flips Bitcoin, ETH Co-Founder Asserts
  2. The Bitcoin Comeback: Will It Retake $28K Before August Ends?
  3. The Memecoin Craze: How BRC-20 Tokens Are Making Their Mark on the Bitcoin Blockchain
  4. Bitcoin ($BTC) Price Hitting $1 Million Easier Than Expected If US Approves Spot ETF, Analyst Reveals
  5. Analyst Predicts Bitcoin to Hit $70,000+ Due to BlackRock and Federal Reserve